Waystar (WAY) said it will acquire health AI software company, Iodine Software, for a total enterprise value of $1.25B. The ...

Waystar plans to acquire AI-driven revenue cycle management company Iodine Software, its first acquisition since going public ...

Healthcare-software company Waystar has agreed to buy private-equity backed Iodine Software for $1.25 billion, including debt ...

Healthcare software firm Waystar said on Wednesday it would buy privately held Iodine Software in a deal worth over $1.25 billion, including debt, to expand its use of artificial intelligence in ...

Waystar has signed a definitive agreement to acquire AI-powered revenue cycle management company Iodine Software. The proposed $1.25 billion deal will be funded with a 50/50 mix of cash and stock ...

Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced a definitive agreement to acquire ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Louisville's newest public company raises nearly $1 billion © 2025 American City Business Journals. All rights reserved. Use ...

Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.

Waystar Holding Corp. shows revenue growth and strategic expansion with the Iodine acquisition. Click for why high valuations and muted growth may temper WAY's appeal.

This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.

Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on ...